The study authors propose the creation of a not-for-profit service, which they call the "Global Health Accelerator (GHA) project," that "would help get innovative NTD-related health products to distant markets by connecting a diverse international community of biotech innovators, facilitate public-private partnerships, provide business support services, and operate as an independent hub linking companies, investors, and interested parties," the news service writes. "We think of the Global Health Accelerator as a FedEx for new drugs, vaccines and diagnostics to combat neglected tropical diseases" Singer said (Leahy, 11/3).
Full Article at Medical News Today